Beth S Woods

Summary

Affiliation: Oxford Outcomes
Country: UK

Publications

  1. doi request reprint Raltitrexed plus cisplatin is cost-effective compared with pemetrexed plus cisplatin in patients with malignant pleural mesothelioma
    Beth Woods
    Oxford Outcomes, Oxford, UK
    Lung Cancer 75:261-7. 2012
  2. pmc Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: a tutorial
    Beth S Woods
    Oxford Outcomes Ltd, Oxford, UK
    BMC Med Res Methodol 10:54. 2010
  3. doi request reprint Prioritizing pharmacogenetic research: a value of information analysis of CYP2D6 testing to guide breast cancer treatment
    Beth Woods
    Oxford Outcomes Ltd, Oxford, United Kingdom
    Value Health 14:989-1001. 2011
  4. doi request reprint No study left behind: a network meta-analysis in non-small-cell lung cancer demonstrating the importance of considering all relevant data
    Neil Hawkins
    Oxford Outcomes Ltd, Oxford, UK
    Value Health 12:996-1003. 2009

Detail Information

Publications4

  1. doi request reprint Raltitrexed plus cisplatin is cost-effective compared with pemetrexed plus cisplatin in patients with malignant pleural mesothelioma
    Beth Woods
    Oxford Outcomes, Oxford, UK
    Lung Cancer 75:261-7. 2012
    ....
  2. pmc Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: a tutorial
    Beth S Woods
    Oxford Outcomes Ltd, Oxford, UK
    BMC Med Res Methodol 10:54. 2010
    ..Network meta-analysis, an extension of traditional pairwise meta-analysis, is typically based on a single statistic. In this case, studies which do not report the chosen statistic are excluded from the analysis which may introduce bias...
  3. doi request reprint Prioritizing pharmacogenetic research: a value of information analysis of CYP2D6 testing to guide breast cancer treatment
    Beth Woods
    Oxford Outcomes Ltd, Oxford, United Kingdom
    Value Health 14:989-1001. 2011
    ....
  4. doi request reprint No study left behind: a network meta-analysis in non-small-cell lung cancer demonstrating the importance of considering all relevant data
    Neil Hawkins
    Oxford Outcomes Ltd, Oxford, UK
    Value Health 12:996-1003. 2009
    ..To demonstrate the importance of considering all relevant indirect data in a network meta-analysis of treatments for non-small-cell lung cancer (NSCLC)...